ACUT — ACCUSTEM SCIENCES Balance Sheet
0.000.00%
Last trade - 00:00
- $4.51m
- $4.53m
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Cash and Equivalents | ||||
Cash and Short Term Investments | — | — | 0.734 | 0.021 |
Net Total Receivables | 1.37 | 1.35 | 0 | — |
Prepaid Expenses | ||||
Total Other Current Assets | ||||
Total Current Assets | 1.37 | 1.35 | 0.932 | 0.13 |
Gross Property, Plant And Equipment | ||||
Accumulated Depreciation | ||||
Net Property, Plant And Equipment | — | — | 0.008 | 0.004 |
Total Assets | 1.37 | 1.35 | 0.94 | 0.134 |
Accounts Payable | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 0.055 | 0.703 | 1.08 | 2.25 |
Total Long Term Debt | ||||
Total Debt | ||||
Total Liabilities | 0.055 | 0.703 | 1.08 | 2.25 |
Common Stock | ||||
Additional Paid In Capital | ||||
Retained Earnings (Accumulated Deficit) | ||||
Other Equity | ||||
Total Equity | 1.31 | 0.651 | -0.14 | -2.11 |
Total Liabilities & Shareholders' Equity | 1.37 | 1.35 | 0.94 | 0.134 |
Total Common Shares Outstanding |